(Q40856302)

English

Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party

scientific article published on December 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Paesmans M

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sculier JP

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Libert P

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Bureau G

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Dabouis G

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Thiriaux J

6

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Michel J

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Van Cutsem O

8

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sergysels R

9

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Mommen P

10

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Klastersky J

11

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

1 December 1997

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

European Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

33

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

2326-2332

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Historical notes on lung cancer before and after Graham's successful pneumonectomy in 1933

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy of lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trials of radiotherapy alone versus combined chemotherapy and radiotherapy in stages IIIa and IIIb nonsmall cell lung cancer. A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of survival by tumor response.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression and recursive partition strategies in the analysis of medical survival data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

An improved Bonferroni procedure for multiple tests of significance

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900325-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0959-8049(97)00325-0

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40856302&oldid=1908852793"